Aug 21, 2018
Jeff Missling
SpineThera

Jeff has built SpineThera as a semi-virtual company with in-house formulation development and pilot plant operations and contracted services for all supporting functions. Jeff has further established a world class team of clinical and regulatory consultants (C-level and FDA director level). Mr. Missling has an extensive background in formulation, preclinical, and clinical development of polymeric, sustained release products including biodegradable microspheres, ophthalmic implants, drug coated medical devices, and biodegradable implants. Before founding SpineThera, Jeff led the formulation development and clinical study manufacturing of a sustained release steroid implant for ocular administration that was licensed to Merck for $40M. A chemical engineer trained at the University of Wisconsin-Madison, Jeff has spent his career developing functional polymeric materials including polymeric batteries, medical devices, and sustained-release drug products.

Sponsors